Shares of Idorsia Ltd (OTCMKTS:IDRSF – Get Free Report) were down 9.9% on Monday . The company traded as low as $1.18 and last traded at $1.18. Approximately 191 shares traded hands during mid-day trading, a decline of 68% from the average daily volume of 599 shares. The stock had previously closed at $1.31.
Idorsia Trading Down 2.5 %
The company has a 50-day moving average of $0.99 and a 200-day moving average of $1.36.
About Idorsia
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.
Featured Articles
- Five stocks we like better than Idorsia
- 10 Best Airline Stocks to Buy
- Energy Transfer: Powering Data With Dividends and Diversification
- Stock Market Sectors: What Are They and How Many Are There?
- Qualcomm Stock Is Coiling for a Breakout
- What Are Earnings Reports?
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Idorsia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idorsia and related companies with MarketBeat.com's FREE daily email newsletter.
